Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Immunic Inc (NASDAQ: IMUX) closed the day trading at $0.91 down -6.73% from the previous closing price of $0.98. In other words, the price has decreased by -$6.73 from its previous closing price. On the day, 1.21 million shares were traded. IMUX stock price reached its highest trading level at $0.995 during the session, while it also had its lowest trading level at $0.8911.
Ratios:
For a better understanding of IMUX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On November 25, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’25 when Nash Duane bought 20,000 shares for $0.83 per share. The transaction valued at 16,694 led to the insider holds 36,032 shares of the business.
Tardio Jason bought 12,512 shares of IMUX for $9,884 on Jun 05 ’25. The President and COO now owns 12,512 shares after completing the transaction at $0.79 per share. On Jun 04 ’25, another insider, Vitt Daniel, who serves as the CEO and Director of the company, bought 15,000 shares for $0.77 each. As a result, the insider paid 11,550 and bolstered with 29,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMUX now has a Market Capitalization of 90028536 and an Enterprise Value of 35697528.
Stock Price History:
The Beta on a monthly basis for IMUX is 1.45, which has changed by -0.43987727 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 5.84%, while the 200-Day Moving Average is calculated to be -9.92%.
Shares Statistics:
Over the past 3-months, IMUX traded about 1.69M shares per day on average, while over the past 10 days, IMUX traded about 1219100 shares per day. A total of 98.65M shares are outstanding, with a floating share count of 95.28M. Insiders hold about 3.42% of the company’s shares, while institutions hold 69.60% stake in the company. Shares short for IMUX as of 1753920000 were 9783401 with a Short Ratio of 5.79, compared to 1751241600 on 8954528. Therefore, it implies a Short% of Shares Outstanding of 9783401 and a Short% of Float of 10.100000000000001.
Earnings Estimates
The current market rating for Immunic Inc (IMUX) reflects the collective analysis of 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.02 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.52 and -$0.86 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.5, with 5.0 analysts recommending between -$0.18 and -$1.01.
